Journal of Infection and Chemotherapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.7 | Q3 | 25.3% | 0.503 | Q3 | 61.1% |
| 2024 | 1.5 | Q4 | 24.6% | 0.584 | Q2 | 67.5% |
| 2023 | 1.9 | Q3 | 36.8% | 0.579 | Q2 | 69.7% |
| 2022 | 2.2 | Q4 | 36.8% | 0.576 | Q2 | 70.7% |
| 2021 | 2.1 | Q4 | 37.6% | 0.588 | Q2 | 72.2% |
| 2020 | — | — | 0.838 | Q2 | 81.0% | |
| 2019 | — | — | 0.691 | Q2 | 76.6% | |
| 2018 | — | — | 0.754 | Q2 | 77.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1341-321X
ISSN
1437-7780
country
NLcoverage
1995-2026